FMR LLC 13D and 13G filings for Compass Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 08:50 am Sale |
2024-02-08 | 13G | Compass Therapeutics, Inc. CMPX |
FMR LLC | 4,551,506 3.570% |
-1,803,308 (-28.38%) |
Filing |
| 2023-02-09 08:14 am Sale |
2023-02-09 | 13G | Compass Therapeutics, Inc. CMPX |
FMR LLC | 6,354,814 5.035% |
-517,600 (-7.53%) |
Filing |
| 2022-02-09 09:11 am Purchase |
2022-02-08 | 13G | Compass Therapeutics, Inc. CMPX |
FMR LLC | 6,872,414 7.010% |
2,750,000 (+66.71%) |
Filing |
| 2021-02-08 10:19 am Purchase |
2021-02-05 | 13G | Compass Therapeutics, Inc. CMPX |
FMR LLC | 4,122,414 6.744% |
4,122,414 (New Position) |
Filing |